Genitourinary oncology encompasses cancers of the urinary system and male reproductive organs and continues to benefit from rapid advances in imaging, surgery, systemic treatment, targeted therapies, and immunotherapy. This session provides a multidisciplinary platform for research and clinical developments across genitourinary malignancies.
Abstract Scope and Participation
Submissions may address prostate, kidney, bladder, urothelial, testicular, penile, and other genitourinary cancers. Research on diagnosis, biomarkers, surgery, radiotherapy, hormonal therapy, targeted treatment, immunotherapy, and advanced disease management is welcomed from clinicians, scientists, surgeons, and multidisciplinary teams.







Title : Long-read sequencing reveals dynamic features of human malignancies
Jianhua Luo, University of Pittsburgh School of Medicine, United States
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States